Dominant mutations in familial lethal and severe osteogenesis imperfecta.
Four families presenting with familial osteogenesis imperfecta (OI) have been studied: 2 with the lethal type II and 2 with the severe type III form. Fibroblasts of the patients, all issue from non-consanguineous parents, produced normal and abnormal alpha(I) chains. These heterozygous mutations differentiate the recurrent forms from homozygous mutations characteristic of autosomal recessive forms. Although the identity of the mutations could not be determined, such recurrence of autosomal dominant OI is probably the result of germinal mosaicism in one of the parents. Biochemical results were consistent with a somatic mosaicism in the father's fibroblasts in one family. Moreover, our studies show that not only OI type II but also severe OI type III can arise from gonadal mosaicism. We discuss the importance of such a phenomenon for genetic counseling.
Cohen-Solal
L
L
Laboratoire de Physiopathologie, URA 584 CNRS, Hôpital Necker, Paris, France.
Bonaventure
J
J
Maroteaux
P
P
D000028:Abortion, Induced; D000328:Adult; D002478:Cells, Cultured; D003094:Collagen / Q000096:biosynthesis / Q000737:chemistry; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D005799:Genes, Dominant; D005817:Genetic Counseling; D005865:Gestational Age; D006801:Humans; D008297:Male; D009154:Mutation; D010013:Osteogenesis Imperfecta / Q000196:embryology / Q000235:genetics*; D010449:Peptide Mapping; D011247:Pregnancy; D011489:Protein Denaturation; D012995:Solubility; D013696:Temperature
D003094:Collagen